These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 15550505)

  • 1. Autocrine activation of the local insulin-like growth factor I system is up-regulated by estrogen receptor (ER)-independent estrogen actions and accounts for decreased ER expression in type 2 diabetic mesangial cells.
    Karl M; Potier M; Schulman IH; Rivera A; Werner H; Fornoni A; Elliot SJ
    Endocrinology; 2005 Feb; 146(2):889-900. PubMed ID: 15550505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low insulin-like growth factor binding protein-2 expression is responsible for increased insulin receptor substrate-1 phosphorylation in mesangial cells from mice susceptible to glomerulosclerosis.
    Fornoni A; Rosenzweig SA; Lenz O; Rivera A; Striker GE; Elliot SJ
    Endocrinology; 2006 Jul; 147(7):3547-54. PubMed ID: 16556765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen-related abnormalities in glomerulosclerosis-prone mice: reduced mesangial cell estrogen receptor expression and prosclerotic response to estrogens.
    Potier M; Karl M; Zheng F; Elliot SJ; Striker GE; Striker LJ
    Am J Pathol; 2002 May; 160(5):1877-85. PubMed ID: 12000739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autocrine activation of the IGF-I signaling pathway in mesangial cells isolated from diabetic NOD mice.
    Tack I; Elliot SJ; Potier M; Rivera A; Striker GE; Striker LJ
    Diabetes; 2002 Jan; 51(1):182-8. PubMed ID: 11756339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen receptor alpha (ERalpha) and insulin-like growth factor I receptor (IGF-IR) cross-talk in the gonadotropic alphaT3-1 cell line.
    Eertmans F; Dhooge W; De Wever O; Bracke M; Comhaire F; Kaufman JM
    J Cell Physiol; 2007 Sep; 212(3):583-90. PubMed ID: 17458895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SPARC regulates cell cycle progression in mesangial cells via its inhibition of IGF-dependent signaling.
    Francki A; Motamed K; McClure TD; Kaya M; Murri C; Blake DJ; Carbon JG; Sage EH
    J Cell Biochem; 2003 Mar; 88(4):802-11. PubMed ID: 12577314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender-specific effects of endogenous testosterone: female alpha-estrogen receptor-deficient C57Bl/6J mice develop glomerulosclerosis.
    Elliot SJ; Berho M; Korach K; Doublier S; Lupia E; Striker GE; Karl M
    Kidney Int; 2007 Aug; 72(4):464-72. PubMed ID: 17495854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human neuroblastoma cells use either insulin-like growth factor-I or insulin-like growth factor-II in an autocrine pathway via the IGF-I receptor: variability of IGF, IGF binding protein (IGFBP) and IGF receptor gene expression and IGF and IGFBP secretion in human neuroblastoma cells in relation to cellular proliferation.
    Kiess W; Koepf G; Christiansen H; Blum WF
    Regul Pept; 1997 Sep; 72(1):19-29. PubMed ID: 9404729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen receptor regulates insulin-like growth factor-I receptor gene expression in breast tumor cells: involvement of transcription factor Sp1.
    Maor S; Mayer D; Yarden RI; Lee AV; Sarfstein R; Werner H; Papa MZ
    J Endocrinol; 2006 Dec; 191(3):605-12. PubMed ID: 17170218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.
    Sachdev D; Li SL; Hartell JS; Fujita-Yamaguchi Y; Miller JS; Yee D
    Cancer Res; 2003 Feb; 63(3):627-35. PubMed ID: 12566306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of insulin-like growth factor signaling in human breast cancer: estrogen regulation of insulin receptor substrate-1 expression in vitro and in vivo.
    Lee AV; Jackson JG; Gooch JL; Hilsenbeck SG; Coronado-Heinsohn E; Osborne CK; Yee D
    Mol Endocrinol; 1999 May; 13(5):787-96. PubMed ID: 10319328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-like growth factor binding protein-4 and -5 modulate ligand-dependent estrogen receptor-α activation in breast cancer cells in an IGF-independent manner.
    Hermani A; Shukla A; Medunjanin S; Werner H; Mayer D
    Cell Signal; 2013 Jun; 25(6):1395-402. PubMed ID: 23499909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 17beta-estradiol up-regulates the insulin-like growth factor receptor through a nongenotropic pathway in prostate cancer cells.
    Pandini G; Genua M; Frasca F; Squatrito S; Vigneri R; Belfiore A
    Cancer Res; 2007 Sep; 67(18):8932-41. PubMed ID: 17875736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IGF-1 decreases collagen degradation in diabetic NOD mesangial cells: implications for diabetic nephropathy.
    Lupia E; Elliot SJ; Lenz O; Zheng F; Hattori M; Striker GE; Striker LJ
    Diabetes; 1999 Aug; 48(8):1638-44. PubMed ID: 10426384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased activity of the insulin-like growth factor system in mesangial cells cultured in high glucose conditions. Relation to glucose-enhanced extracellular matrix production.
    Pugliese G; Pricci F; Locuratolo N; Romeo G; Romano G; Giannini S; Cresci B; Galli G; Rotella CM; Di Mario U
    Diabetologia; 1996 Jul; 39(7):775-84. PubMed ID: 8817101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the insulin-like growth factor system on an estrogen-dependent cancer phenotype in the MCF-7 human breast cancer cell line.
    Bradley LM; Gierthy JF; Pentecost BT
    J Steroid Biochem Mol Biol; 2008 Mar; 109(1-2):185-96. PubMed ID: 18337089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of insulin-like growth factor I receptors in diabetic mesangial cells.
    Oemar BS; Foellmer HG; Hodgdon-Anandant L; Rosenzweig SA
    J Biol Chem; 1991 Feb; 266(4):2369-73. PubMed ID: 1846626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nandrolone and stanozolol induce Leydig cell tumor proliferation through an estrogen-dependent mechanism involving IGF-I system.
    Chimento A; Sirianni R; Zolea F; De Luca A; Lanzino M; Catalano S; Andò S; Pezzi V
    J Cell Physiol; 2012 May; 227(5):2079-88. PubMed ID: 21769864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
    Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
    Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expression of estrogen receptor isoforms alpha, beta and insulin-like growth factor-I in uterine leiomyoma.
    Zhao Y; Zhang W; Wang S
    Gynecol Endocrinol; 2008 Oct; 24(10):549-54. PubMed ID: 19012097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.